$1.8 B

IRWD Mkt cap, 14-Dec-2018

$65.7 M

Ironwood Pharmaceuticals Revenue Q3, 2018
Ironwood Pharmaceuticals Net income (Q3, 2018)-174.4 M
Ironwood Pharmaceuticals EBIT (Q3, 2018)-169.1 M
Ironwood Pharmaceuticals Cash, 30-Sep-2018141.6 M

Ironwood Pharmaceuticals Income Statement

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

22.9m76.4m149.6m274.0m298.3m

Revenue growth, %

234%96%83%

Cost of goods sold

12.0k

Gross profit

149.5m

Gross profit Margin, %

100%

R&D expense

102.4m108.7m139.5m148.2m

General and administrative expense

123.2m125.2m173.3m233.1m

Operating expense total

225.6m234.0m312.8m381.4m

EBIT

(252.0m)(169.4m)(102.1m)(51.9m)(77.4m)

EBIT margin, %

(1101%)(222%)(68%)(19%)(26%)

Interest expense

21.0m31.1m39.2m36.4m

Net Income

(272.8m)(189.6m)(142.7m)(81.7m)(116.9m)

Ironwood Pharmaceuticals Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

75.5m74.3m261.3m54.0m125.7m

Accounts Receivable

513.0k10.0k2.9m933.0k3.2m

Inventories

22.1m10.6m6.3m1.1m735.0k

Current Assets

229.1m289.7m500.2m380.2m311.6m

PP&E

37.4m29.8m21.1m20.5m17.3m

Goodwill

785.0k785.0k

Total Assets

279.0m333.5m619.1m709.8m605.7m

Accounts Payable

10.1m9.8m8.6m17.7m16.0m

Short-term debt

1.1m1.2m2.6m6.2m4.1m

Current Liabilities

41.0m60.5m76.5m91.1m66.0m

Long-term debt

174.7m249.2m

Total Debt

175.8m2.6m6.2m253.3m

Common Stock

103.0k125.0k127.0k133.0k137.0k

Additional Paid-in Capital

815.9m1.1b1.2b1.3b1.3b

Retained Earnings

(777.8m)(967.4m)(1.1b)(1.2b)(1.3b)

Total Equity

38.2m88.6m95.1m66.7m9.8m

Debt to Equity Ratio

4.6 x0.1 x

Debt to Assets Ratio

0.6 x0 x

Financial Leverage

7.3 x3.8 x6.5 x10.6 x61.5 x

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Cash

144.5m205.1m95.4m51.3m63.7m256.5m248.1m280.9m277.3m182.9m133.3m182.1m162.6m144.8m145.4m141.6m

Accounts Receivable

125.0k13.0k380.0k862.0k1.1m2.6m908.0k1.3m1.2m1.2m4.0m4.3m5.0m6.7m10.2m

Inventories

20.6m23.4m13.0m13.0m5.0m1.5m1.1m479.0k1.7m1.1m76.0k

Current Assets

275.8m371.3m325.8m304.1m263.9m527.0m505.8m495.7m386.1m382.8m357.9m341.5m314.1m275.7m279.5m248.5m

PP&E

37.2m35.5m33.6m30.4m27.5m25.0m23.2m19.4m17.9m18.8m18.6m17.9m17.2m16.8m16.3m16.2m

Goodwill

649.0k649.0k785.0k785.0k785.0k785.0k785.0k785.0k

Total Assets

325.8m418.9m371.1m346.2m305.5m653.9m613.4m603.3m700.2m732.0m701.3m705.1m625.1m571.1m618.2m416.7m

Accounts Payable

2.4m4.8m3.4m6.1m

Short-term debt

1.1m1.2m1.1m1.1m1.2m1.2m2.3m2.4m2.5m3.5m5.5m5.1m4.4m3.4m2.5m

Current Liabilities

39.7m38.5m41.6m54.1m59.8m62.1m67.8m78.1m91.0m95.3m78.9m80.0m64.5m62.3m95.0m112.6m

Long-term debt

174.7m237.9m241.5m245.3m

Total Debt

175.8m1.2m1.1m1.1m1.2m1.2m2.3m2.4m2.5m3.5m243.4m246.6m249.7m3.4m2.5m

Common Stock

97.0k119.0k120.0k124.0k126.0k126.0k127.0k128.0k130.0k131.0k134.0k135.0k135.0k138.0k139.0k140.0k

Additional Paid-in Capital

809.9m1.0b1.0b1.0b1.1b1.2b1.2b1.2b1.2b1.2b1.3b1.3b1.3b1.3b1.4b1.4b

Retained Earnings

(725.8m)(827.5m)(887.8m)(929.8m)(1.0b)(1.0b)(1.1b)(1.1b)(1.1b)(1.2b)(1.2b)(1.3b)(1.3b)(1.4b)(1.4b)(1.6b)

Total Equity

84.2m188.9m141.8m108.2m68.2m140.3m100.5m90.9m81.4m59.5m29.6m4.9m(17.6m)

Debt to Equity Ratio

0 x0 x0 x0 x0 x0 x0 x0.1 x8.2 x50.6 x-14.2 x

Debt to Assets Ratio

0 x0 x0 x0 x0 x0 x0 x0 x0.3 x0.3 x0.4 x0 x0 x

Financial Leverage

3.9 x2.2 x2.6 x3.2 x4.5 x4.7 x6.1 x6.6 x8.6 x12.3 x23.7 x144.8 x-35.6 x

Ironwood Pharmaceuticals Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(272.8m)(189.6m)(142.7m)(81.7m)(116.9m)

Depreciation and Amortization

11.7m12.3m11.6m10.3m8.4m

Accounts Receivable

(1.7m)(24.0m)(28.7m)(10.3m)(17.3m)

Inventories

(11.9m)(3.9m)2.6m(3.1m)346.0k

Accounts Payable

(11.7m)1.4m

Cash From Operating Activities

(273.4m)(155.6m)(106.9m)(25.4m)(99.6m)

Purchases of PP&E

(9.6m)(3.5m)(4.0m)(4.2m)(4.2m)

Cash From Investing Activities

(101.4m)(56.6m)151.5m

Cash From Financing Activities

313.6m210.9m303.1m(4.2m)19.8m

Interest Paid

18.4m19.6m22.7m24.5m20.4m
Report incorrect company information

Ironwood Pharmaceuticals Employee Rating

3.948 votes
Culture & Values
3.8
Work/Life Balance
3.9
Senior Management
3.3
Salary & Benefits
3.9
Career Opportunities
3.3
Source